JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Accounts receivable | 72.42%52.39B | 23.49%26.41B | 37.72%30.17B | 31.39%33.31B | 31.27%30.38B | -19.83%21.39B | -37.08%21.91B | -22.51%25.35B | -33.66%23.15B | -2.21%26.68B |
Withholding and tax receivable | 651.35%278M | 564.29%279M | 264.29%51M | 276.47%64M | --37M | --42M | 133.33%14M | -10.53%17M | ---- | ---- |
Cash and equivalents | 63.96%227.76B | 3.64%153.99B | -21.75%135.9B | -32.36%125.11B | -20.80%138.91B | -29.08%148.58B | -34.34%173.68B | 1.99%184.97B | -0.60%175.4B | 35.49%209.5B |
Financial assets at fair value-current assets | 2.34%6.53B | 6.30%6.8B | 5.08%6.68B | 2.91%6.36B | -94.57%6.38B | -96.23%6.39B | -97.24%6.36B | -27.25%6.18B | -5.67%117.55B | 30.62%169.51B |
Derivative financial instruments-current assets | 72.03%93.37B | 32.41%91.46B | -17.74%56.69B | -27.99%58.13B | --54.27B | --69.07B | --68.92B | -11.71%80.72B | ---- | ---- |
Special items of current assets | -11.41%77.68B | -0.58%86.72B | 0.45%85.42B | 9.37%93.23B | 23.46%87.69B | 4.45%87.23B | 22.58%85.04B | 39.62%85.25B | -10.32%71.02B | 15.10%83.52B |
Total current assets | 44.17%458B | 9.91%365.66B | -11.52%314.9B | -17.33%316.2B | -17.94%317.67B | -31.99%332.71B | -40.56%355.91B | 1.98%382.48B | -6.76%387.13B | 27.32%489.2B |
Non-current assets | ||||||||||
Fixed assets | 0.75%1.47B | -2.79%1.46B | -4.94%1.5B | -5.30%1.55B | -7.84%1.46B | -5.35%1.51B | 1.15%1.58B | 2.18%1.64B | 5.68%1.58B | 2.38%1.59B |
Interests in Joint Venture | 19.82%399M | 29.45%400M | 21.54%378M | 20.96%352M | 20.65%333M | 17.94%309M | 15.61%311M | 19.26%291M | 24.32%276M | 29.70%262M |
Financial assets at fair value-non-current assets | -14.69%697M | -30.47%575M | -23.58%606M | -23.25%604M | 1.49%817M | -12.02%827M | -14.36%793M | -16.81%787M | -4.51%805M | 12.31%940M |
Goodwill | 1.55%19.46B | 1.72%19.41B | 1.52%19.37B | 1.64%19.28B | 0.78%19.16B | 0.46%19.08B | 0.38%19.08B | -0.02%18.97B | 0.52%19.02B | 0.53%19B |
Deferred tax assets | -91.80%5M | -58.33%15M | -21.21%26M | -60.38%21M | -30.68%61M | -47.83%36M | -8.33%33M | 112.00%53M | 144.44%88M | 91.67%69M |
Special items of non-current assets | -0.58%1.54B | 8.31%1.66B | 628.63%1.71B | 632.17%1.68B | 569.26%1.55B | 544.73%1.53B | -35.36%234M | -57.95%230M | -45.52%231M | -43.97%237M |
Total non-current assets | 10.68%27.46B | 11.90%27.74B | 6.11%25.03B | 5.96%24.98B | 4.80%24.81B | 3.95%24.79B | -1.67%23.59B | -2.73%23.57B | -0.95%23.67B | -0.58%23.85B |
Total assets | 41.75%485.46B | 10.04%393.4B | -10.43%339.93B | -15.98%341.18B | -16.63%342.48B | -30.32%357.49B | -39.06%379.5B | 1.69%406.05B | -6.44%410.8B | 25.68%513.05B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | 142.81%73.47B | 31.94%26.24B | 15.33%21.07B | 46.16%27.85B | 65.49%30.26B | 0.04%19.89B | -32.38%18.27B | -32.75%19.05B | -28.55%18.28B | 16.62%19.88B |
Tax payable | -11.95%1.18B | -19.09%839M | -23.91%525M | -70.58%639M | -28.17%1.34B | -32.75%1.04B | -41.08%690M | 88.38%2.17B | -17.78%1.86B | -11.43%1.54B |
Advance payment | 27.87%232.35B | -0.24%187.45B | -13.72%186.47B | -22.70%176.17B | -10.58%181.71B | -24.67%187.9B | -28.27%216.13B | 11.97%227.9B | -8.19%203.21B | 30.36%249.45B |
Bank loans and overdrafts | -11.78%382M | -11.57%382M | -11.37%382M | -11.16%382M | 27.35%433M | 27.06%432M | 26.76%431M | 26.47%430M | 0.00%340M | 0.00%340M |
Derivative financial instrument-current liabilities | 71.86%93.33B | 32.55%91.51B | -17.68%56.71B | -28.01%58.1B | --54.31B | --69.04B | --68.89B | -11.72%80.71B | ---- | ---- |
Provision-current liabilities | 5.63%75M | 2.53%81M | 6.02%88M | -7.46%62M | -28.28%71M | -26.85%79M | -18.63%83M | -18.29%67M | -13.91%99M | -14.29%108M |
Financial lease liabilities-current liabilities | 4.45%258M | -3.85%250M | -4.59%270M | -9.09%270M | -18.48%247M | -13.33%260M | -6.91%283M | -0.67%297M | 2.71%303M | 0.33%300M |
Deferred income-current liabilities | -2.16%498M | -2.50%703M | -0.97%915M | -1.49%1.06B | -0.20%509M | -3.48%721M | -2.43%924M | -2.18%1.08B | -1.54%510M | 3.03%747M |
Special items of current liabilities | 40.69%30.18B | 29.64%30.04B | -4.40%20.74B | 3.48%21.98B | -84.21%21.45B | -87.68%23.17B | -91.00%21.69B | 7.87%21.25B | -1.36%135.82B | 31.47%188.05B |
Total current liabilities | 48.70%431.72B | 11.56%337.5B | -12.29%287.16B | -18.82%286.51B | -19.45%290.32B | -34.29%302.53B | -42.77%327.38B | 2.02%352.95B | -7.14%360.43B | 29.81%460.41B |
Net current assets | -3.89%26.28B | -6.67%28.17B | -2.76%27.74B | 0.55%29.69B | 2.43%27.35B | 4.83%30.18B | 7.02%28.53B | 1.46%29.53B | -1.18%26.7B | -2.63%28.79B |
Total assets less current liabilities | 3.04%53.74B | 1.70%55.9B | 1.26%52.77B | 2.95%54.67B | 3.54%52.16B | 4.43%54.97B | 2.90%52.12B | -0.44%53.1B | -1.07%50.37B | -1.71%52.64B |
Non-current liabilities | ||||||||||
Long-term bank loan | 6.25%68M | 6.35%67M | 6.45%66M | 6.56%65M | -28.09%64M | -28.41%63M | -28.74%62M | -29.07%61M | 3.49%89M | 3.53%88M |
Financial lease liabilities-non-current liabilities | -15.43%1.1B | -14.75%1.16B | -8.97%1.29B | -7.87%1.33B | -13.25%1.3B | -14.38%1.36B | -15.61%1.42B | -17.73%1.45B | -17.74%1.5B | -16.30%1.59B |
Deferred tax liability | 0.19%1.03B | -0.58%1.03B | -2.24%1.05B | -1.77%1.05B | -4.19%1.03B | -4.16%1.04B | -4.89%1.07B | -5.30%1.07B | 0.00%1.07B | 0.46%1.08B |
Deferred income-non-current liabilities | -6.05%295M | -4.66%307M | -7.88%304M | -7.81%307M | -7.92%314M | -8.26%322M | -5.71%330M | -5.93%333M | -6.06%341M | -0.28%351M |
Provision-non-current liabilities | 11.71%124M | 5.56%114M | 0.93%108M | 25.56%113M | 16.84%111M | 12.50%108M | 10.31%107M | -8.16%90M | -3.06%95M | -2.04%96M |
Total non-current liabilities | -7.13%2.62B | -7.33%2.68B | -5.76%2.81B | -4.39%2.87B | -9.03%2.82B | -9.85%2.89B | -10.55%2.99B | -12.42%3B | -10.04%3.1B | -8.68%3.21B |
Total liabilities | 48.16%434.33B | 11.38%340.18B | -12.23%289.98B | -18.70%289.38B | -19.36%293.14B | -34.12%305.42B | -42.59%330.37B | 1.88%355.95B | -7.17%363.53B | 29.44%463.62B |
Total assets less total liabilities | 3.62%51.12B | 2.20%53.22B | 1.68%49.96B | 3.39%51.8B | 4.37%49.34B | 5.36%52.07B | 3.85%49.13B | 0.38%50.1B | -0.42%47.27B | -1.23%49.43B |
Total equity and non-current liabilities | 3.04%53.74B | 1.70%55.9B | 1.26%52.77B | 2.95%54.67B | 3.54%52.16B | 4.43%54.97B | 2.90%52.12B | -0.44%53.1B | -1.07%50.37B | -1.71%52.64B |
Equity | ||||||||||
Share capital | 0.09%31.95B | 0.09%31.95B | 0.09%31.95B | 0.09%31.95B | 0.07%31.92B | 0.07%31.92B | 0.07%31.92B | 0.07%31.92B | 0.02%31.9B | 0.02%31.9B |
Exchange reserve | -87.22%-249M | -51.64%-185M | -143.10%-141M | -8.39%-168M | -60.24%-133M | -159.57%-122M | -31.82%-58M | -32.48%-155M | 45.03%-83M | 75.26%-47M |
Other reserves | 53.10%1.56B | 61.27%1.37B | 61.74%1.21B | 65.45%996M | 33.12%1.02B | 24.56%852M | 14.97%745M | 7.50%602M | 10.09%764M | 11.58%684M |
Retained profit | 5.91%18.26B | 3.29%20.72B | 2.53%17.65B | 6.34%19.72B | 10.35%17.24B | 13.12%20.06B | 10.69%17.22B | 2.06%18.55B | 0.52%15.62B | -2.59%17.73B |
Special items of shareholders' rights and interests | 20.07%-924M | -8.34%-1.14B | -8.61%-1.19B | 2.62%-1.15B | 3.43%-1.16B | 4.95%-1.06B | -6.33%-1.09B | -33.63%-1.18B | -51.90%-1.2B | -43.41%-1.11B |
Shareholders' Equity | 3.48%50.59B | 2.05%52.71B | 1.53%49.48B | 3.25%51.34B | 4.01%48.88B | 5.08%51.65B | 3.62%48.73B | 0.21%49.73B | -0.39%47B | -1.18%49.15B |
Non-controlling interest | 18.28%537M | 21.04%512M | 20.20%482M | 21.83%452M | 66.91%454M | 54.95%423M | 43.21%401M | 30.63%371M | -4.56%272M | -8.39%273M |
Total equity | 3.62%51.12B | 2.20%53.22B | 1.68%49.96B | 3.39%51.8B | 4.37%49.34B | 5.36%52.07B | 3.85%49.13B | 0.38%50.1B | -0.42%47.27B | -1.23%49.43B |
Total equity and total liabilities | 41.75%485.46B | 10.04%393.4B | -10.43%339.93B | -15.98%341.18B | -16.63%342.48B | -30.32%357.49B | -39.06%379.5B | 1.69%406.05B | -6.44%410.8B | 25.68%513.05B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.